Health Care Services

SAM released FY2026 Q3 earnings on May 14, 2026 (SGT) with actual revenue of SGD 3.948 M and EPS of SGD 0

SAM released FY2026 9 Months earnings on May 14, 2026 (SGT), actual revenue SGD 12.21 M, actual EPS SGD -0.0094

SAM released FY2026 Semi-Annual Earnings on February 13, 2026 (SGT), with actual revenue of SGD 8.261 M and EPS of SGD -0.0094

SAM released FY2026 Q1 earnings on February 13, 2026 (SGT), with actual revenue of SGD 4.254 M and EPS of SGD 0

SAM released FY2026 Q2 earnings on February 13, 2026 (SGT) with actual revenue of SGD 4.13 M and EPS of SGD -0.0047

SAM released FY2025 Q4 earnings on August 29 (SGT), actual revenue SGD 3.835 M, actual EPS SGD -0.0068

SAM released FY2024 Q3 earnings on August 29, 2025 (SGT) with actual revenue of SGD 4.049M and EPS of SGD -0.0084

SAM released FY2025 Annual Earnings on August 29, 2025 (SGT), with actual revenue of SGD 15.71 M and EPS of SGD -0.0257

SAM released FY2024 9 Months Earnings on August 29, 2025 (SGT) with actual revenue of SGD 12.6 M and EPS of SGD -0.0395

SAM released FY2025 Q3 earnings on August 29, 2025 (SGT) with actual revenue of SGD 3.835 M and EPS of SGD -0.0068

SAM released FY2024 Q4 earnings on August 29, 2025 (SGT) with actual revenue of SGD 0 and EPS of SGD 0

SAM released FY2025 9 Months earnings on August 29, 2025 (SGT), actual revenue SGD 11.87 M, actual EPS SGD -0.0188

SAM released FY2025 Q2 earnings on February 14 (SGT) with actual revenue of 4.019 M SGD and EPS of -0.006 SGD

SAM released FY2024 Q2 earnings on February 14 (SGT), with actual revenue of 4.274 M SGD and EPS of -0.0155 SGD

SAM released FY2024 Q1 earnings on February 14 (SGT), with actual revenue of 4.274 M SGD and EPS of -0.0155 SGD

SAM released FY2025 Q1 earnings on February 14 (SGT) with actual revenue of 4.019 M SGD and actual EPS of -0.006 SGD

SAM released FY2024 Semi-Annual Earnings on February 14, 2025 (SGT) with actual revenue of 8.547 M SGD and EPS of -0.0311 SGD

SAM released FY2025 Semi-Annual Earnings on February 14 (SGT), with actual revenue of 8.038 M SGD and actual EPS of -0.012 SGD

SAM released FY2024 Annual Earnings on October 29 (SGT) with actual revenue of 16.65 M SGD and EPS of -0.0455 SGD

SAM released FY2023 Annual Earnings on February 2, 2024 (SGT) with actual revenue of 16,233,651 and EPS of -0.0266

SingtelMBeCW260730

Abundance

Geely MB ePW261005

Asiatic

HSI 28000MBePW260629

Alibaba MB eCW260703

Teho

NKY 55000MBePW260911

NKY 52000MBePW260612

Jadason

<p>Singapore Institute of Advanced Medicine Holdings Ltd. has received approval from the Singapore Exchange for a renounceable non-underwritten rights cum warrants issue. The offer includes up to 492.6 million new shares at S$0.031 each and an equal number of free detachable warrants exercisable at S$0.050. This fundraising structure allows existing shareholders to participate in capital raising, with further announcements expected as the transaction progresses. The company operates in advanced medical diagnostics and treatment services and is listed on the Catalist board of the Singapore Exchange.</p>

Tip Ranks

Singapore Institute of Advanced Medicine Wins SGX Nod for Major Rights and Warrants Issue

SAM(9G2.SG)

Singapore Institute of Advanced Medicine Wins SGX Nod for Major Rights and Warrants Issue